Trial intelligence / Profile preview

Epiphysiodesis for adolescents: postoperative pain treatment RCT

2015-000870-36Phase 4Active

Sponsor
Máxima Medisch Centrum
Start
Mar 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of bupivacaine and morphine in gigantism (2 arms), sponsored by Máxima Medisch Centrum. Primary endpoint: Postoperative pain during first 5 days. Started Mar 2015; status: active.

02

Drugs

bupivacainemorphine
03

Conditions

gigantism

Beyond the preview

Go deeper on 2015-000870-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-000870-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call